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Abstract
We describe a novel in vitro cloning strategy that combines standard tools in molecular biology with a basic protecting
group concept to create a versatile framework for the rapid and seamless assembly of modular DNA building blocks into
functional open reading frames. Analogous to chemical synthesis strategies, our assembly design yields idempotent
composite synthons amenable to iterative and recursive split-and-pool reaction cycles. As an example, we illustrate the
simplicity, versatility and efficiency of the approach by constructing an open reading frame composed of tandem arrays of a
human fibronectin type III (FNIII) domain and the von Willebrand Factor A2 domain (VWFA2), as well as chimeric (FNIII)n-
VWFA2-(FNIII)n constructs. Although we primarily designed this strategy to accelerate assembly of repetitive constructs for
single-molecule force spectroscopy, we anticipate that this approach is equally applicable to the reconstitution and
modification of complex modular sequences including structural and functional analysis of multi-domain proteins, synthetic
biology or the modular construction of episomal vectors.
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Introduction
The design and construction of DNA sequences by assembly of
modular DNA fragments lies at the core of protein engineering.
The advent of synthetic biology with associated technological
advances in manufacturing of DNA sequences has recently
matured de novo synthesis of custom genes into an important
resource. In spite of these advances, however, there remains a
continuous demand for robust and cost-effective alternatives,
adaptable by individual laboratories, to aid downstream process-
ing of DNA sequences. This is reflected by the copious and diverse
set of elegant tools and strategies that have been developed to
facilitate ad hoc combinatorial manipulation of DNA sequences and
their transfer into episomal vectors by PCR-based [1–4], ligation-
based [5–7], or recombination-based methods [8,9]. Among the
plethora of available techniques, each has its unique advantages
and not all individual assembly requirements can be met by a
single strategy. For instance, one difficulty encountered by several
applications is the recurrent seamless integration of DNA modules
into serial or tandem arrays. As one such example, single-molecule
force spectroscopy frequently employs repeat proteins to facilitate
the identification of characteristic mechanical fingerprints in the
experimental force-distance data and to accelerate the generation
of statistically relevant datasets. However, only a minor fraction of
proteins biologically occur in a repetitive context. Artificial repeat
constructs (often referred to as ‘‘polyproteins’’) are therefore
typically obtained by recombinant expression of engineered
constructs in which proteins or protein domains are arranged in
tandem arrays [10,11]. At the DNA level, sequential assembly of
such constructs by conventional methods typically relies on
asymmetric recognition sites for restriction endonucleases [12] or
on recycling of restriction sites [2,13]. These methods either lack
control over the exact composition of the assembly product or they
require multi-fragment cloning and a series of time-consuming
subcloning steps [14]. To accelerate the assembly of such
constructs, we recognized the need for a simple and robust
strategy permitting the modular recombination of DNA fragments
in vitro. In multi-step chemical synthesis, efficient strategies have
been developed to systematically assemble combinations of
molecular building blocks into large assortments of diverse
compounds. Surprisingly, several core concepts of these strategies
have not yet been adapted to the assembly of recombinant DNA
sequences, although the prerequisites for the efficient use of such
formats are similar. For instance, chemical synthesis strategies
frequently employ transient protecting groups that allow modular
building blocks (synthons) to be assembled at specific reactive sites
in a defined synthetic sequence. This concept is supported by the
ability to selectively remove these protecting groups with a set of
mutually exclusive (orthogonal) reaction conditions. In the context
of DNA engineering, such molecular building blocks can be
defined as DNA synthons and reactive sites as mutually
compatible, cohesive overhang sequences that permit DNA
ligase-mediated assembly reactions. Likewise, protecting groups
may represent peripheral sequences that can be selectively
eliminated, by for instance specific restriction enzymes, to reveal
cohesive overhang sequences. Directional and recurrent recombi-
nation strategies for DNA synthons can accordingly be realized by
orthogonal deprotection reactions that expose cohesive overhang
sequences at opposite ends of the modules. In the course of any
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sequences permits pasting together complementary synthons. To
our knowledge there has been no reported gene assembly strategy
that exploits the concept of protecting groups for in vitro assembly
of DNA sequences. We here validate applicability of these
principles to the assembly of expression cassettes encoding tandem
arrays of protein domains for single-molecule force spectroscopy.
Results
General Assembly Strategy
A restriction and ligation-based approach to DNA assembly is
introduced that follows the general concept of protecting group-
based chemical synthesis strategies. We implement this strategy by
designing DNA synthons flanked by protecting groups, which can
be selectively removed to expose cohesive overhang sequences.
These attributes allow synthons to enter repeated cycles of
selective deprotection and fusion reactions in vitro, without
requiring subcloning steps. As a key concept of our design, any
assembly operation performed on an arbitrary pair of synthons will
yield an idempotent composite synthon. That is, product synthons
may serve as entry synthons for subsequent assembly steps. The
resulting versatility of this split-and-pool approach allows sequential,
parallel and hierarchical strategies for the assembly of DNA
modules to be employed with minimal screening efforts.
Synthon Design
The concept of protecting groups builds on the ability to
selectively control the site of modification in a scaffolding synthon,
and hence, to precisely define the reaction sequence leading to the
final assembly product. For our purpose this requires the
introduction of two types of protection groups that can be
removed with site-specific (orthogonal) deprotection reactions.
Within the framework of DNA assembly this can be readily met by
exploiting the excellent specificity of restriction endonucleases
towards recognizing and cleaving DNA sequences. In particular,
type IIS restriction endonucleases are able to cleave arbitrary
sequences at a precise distance from their non-palindromic
recognition site and thereby expose user-defined overhang
sequences. This unique property of IIS enzymes has the advantage
that no artifacts are introduced into the synthons if the recognition
site for the enzyme is contained within a flanking sequence that
does not become part of the final assembly.
The application of IIS endonucleases in DNA assembly is not
new, and a number of resourceful strategies have recently emerged
[5,7,15,16]. We here attempt to extend these methods by
introducing a general protecting group strategy that exploits the
unique properties of IIS endonucleases. In our general design, the
ends of synthons are flanked by oppositely oriented recognition
sites for two different IIS endonucleases (Fig. 1A). The choice of
the endonuclease used for excision of the synthon from an entry
vector determines which end of the synthon is protected and which
end is reactive/cohesive. The orthogonal motif, together with
appropriately selected overhang sequences, supports unidirectional
and site-specific assembly of (composite) modules on either end of
the entry synthon (Fig. 1B). In our design we have chosen IIS
endonucleases with 6 base pair recognition sequences, whose
theoretical frequency of occurrence is approximately once in 2048
base pairs (4
6/2), depending on the GC content of the donor
genome. This is sufficiently rare to allow application of this
approach to typical gene fragments; however, prior mutagenesis
may occasionally be required to remove internal sites. From the
wealth of commercially available IIS endonucleases, we chose
BsmBI and BsaI for reasons of robustness and similarity in buffer
and temperature requirements (Table 1). The recognition
sequences of BsmBI and BsaI differ only in a single nucleotide.
Conveniently, another IIS endonuclease, BsmAI, recognizes the
common subset of these recognition sequences, so that one can
optionally combine both cleavage reactions to yield synthons that
are deprotected on both ends.
The IIS endonucleases selected generate 4-base 59-overhangs.
The optimal sequences for these overhangs will depend on the
purpose of the particular assembly design, but several factors
should be carefully considered. First, palindromic overhang
sequences carry the risk of unintended self-ligation. Second, GC-
rich sequences are generally favored in compatible overhangs for
their increased annealing efficiency. This is particularly important
in the context of the short reaction times used in our in vitro
assembly strategy. Third, for designs related to the manipulation of
sequences such as tandem domain assemblies, the choice of
sequences for the junctions primarily depends on which amino
acid sequences will most likely be tolerated within the domain
linker. While we purposely introduced scar sequences in the
application of the strategy reported here, the design in principle
supports seamless assembly formats if the cohesive sequences are
chosen appropriately.
Protecting groups also carry 4-base overhang sequences because
they are excised together with the synthon from an entry vector.
These overhangs must comply with the requirement of being non-
palindromic, mutually non-complimentary and, at the same time,
orthogonal to the cohesive assembly overhangs.
A Split-and-Pool Strategy for Rapid Construct Assembly
The assembly procedure consists of three stages. First, entry
vectors are digested with either of the two IIS endonucleases such
that in each case the resulting entry synthon has a 4-base cohesive
overhang exposed at one end while one of the orthogonal
protecting groups is retained at the opposite end (Fig. 1B).
Subsequently, complementary entry synthons are pooled and
fused by ligation, yielding composite synthons that are idempotent
to the entry synthons by restoration of the orthogonal protecting
group configuration. At each assembly level, the synthons are
digested in parallel with one of the IIS endonucleases essentially as
in the first step. The procedure is reminiscent of split-and-pool
assembly strategies frequently applied in combinatorial chemistry.
Within this framework synthons can enter iterative or recursive
assembly cycles until the required target construct is obtained
(Fig. 1B). Since the assembly of orthogonally deprotected
synthons is unidirectional, only a single product can be formed.
Finally, the assembled product synthons can be ligated back into
the empty entry vector, which may serve as a general repository
vector (see Fig. 1A). Alternatively, the synthons can be directly
cloned into a shuttle vector (pShuttle) for subsequent transfer into
expression plasmids (Fig. 2A). In our laboratory we utilize a
standardized set of expression vectors that uniformly contain 59-
BamHI and 39-NotI restriction sites to facilitate rapid subcloning
of constructs into vectors for different expression hosts and are
equipped with a variety of tag- or signal peptide decorations. The
pShuttle vector is a modified pCR8-TOPO vector carrying a
stuffer sequence that is flanked on both sites by BsaI restriction
sites, which create cohesive overhangs compatible with those from
the deprotected synthons; and additional 59-BamHI and 39-NotI
restriction sites compatible to our in-house library of expression
vectors.
Donor and Acceptor Vectors for Facile Synthon Shuffling
Common to most concatamerization strategies, one technical
limitation arising from our assembly design is that it does not
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product. We realized that such additional versatility can be added
by introducing modular assembly vectors and therefore designed a
compatible pair of donor and acceptor vectors (pDA-N and pDA-
C) that support modular recombination of synthons and insertion
of synthons into a nearly completed assembly product (Fig. 2B).
Similar to the pShuttle vector, these vectors carry a stuffer
sequence flanked by restriction sites for IIS endonucleases to create
overhang sequences compatible with the overhangs of deprotected
synthons. Synthons can be subcloned into pDA-N and pDA-C
vectors, which can either serve as the source of donor synthons or
act as acceptor vectors but differ in the relative position, amino- or
Figure 1. Split-and-pool assembly of DNA synthons. (A) Entry synthons are flanked on both sides by recognition sequences for the type IIS
endonucleases BsaI and BsmBI. Restriction by either BsaI or BsmBI selectively exposes user-definable 4-base cohesive overhang sequences (59-XXXX
vs. 59-xxxx) at one end of the synthon, while maintaining orthogonal protection groups (with 59-YYYY vs. 59-zzzz overhangs) at the opposite end. (B)
Schematic representation of the ‘split-and-pool’ assembly principle. Cohesive ends of entry synthons are selectively deprotected by digestion with
either BsaI or BsmBI. Pooling of the deprotected synthons in the presence of ligase results in unidirectional assembly, affording an idempotent
tandem repeat synthon by restoration of orthogonal protecting groups on opposite ends. Each product module can recursively enter the assembly
cycle (left panel) N times to yield concatameric synthons with 2N elements. The same strategy can be applied to the assembly of heterosynthons
(dashed box), which allows for the engineering of chimeric and multimodular proteins or polycistronic genes.
doi:10.1371/journal.pone.0037617.g001




Sequence NEB buffer T (6C)
BsaI GGTCTCN/NNNN 4o r3 5 0
BsmBI CGTCTCN/NNNN 35 5
BsmAI GTCTCN/NNNN 35 0
doi:10.1371/journal.pone.0037617.t001
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translated assembly product (Fig. 2B, product 1 and 2). Our
design supports two alternative strategies: (i) Recombination of
donor and acceptor vectors using the BsaI restriction site together
with the BamHI or NotI restriction sites as appropriate, leads to
products that have defined 59- and 39-synthons (Fig. 2B, product
3a). (ii) Recombination of donor and acceptor vectors using the
BsmBI restriction site together with the BamHI or NotI restriction
sites as appropriate, leads to products that have defined 59- and 39-
synthons, while retaining two BsaI sites that provide an additional
entry point (Fig. 2B, product 3b). As an example, this design
supports the rapid insertion of proteins of interest to be
sandwiched between fingerprint domains as used frequently in
single-molecule force spectroscopy, or the one-step modification of
open reading frames by insertion of mutant domains (Fig. 2B,
product 4).
Assembly of
13FNIII and von Willebrand Factor A2
Domain Tandem Repeats
We tested the applicability of our approach during the
construction of a series of expression cassettes harboring tandem
arrays of homologous protein domains for single-molecule force
spectroscopy. DNA synthons encoding Asn1813 to Thr1901 of a
fibronectin type III (
13FNIII) domain of human fibronectin [17]
were prepared according to the design principles outlined in
Fig. 1A. The flanking sequences were chosen such that digestion
with BsaI produces a 59-GGGG overhang capable of annealing
with a 59-CCCC overhang present on synthons restricted with
BsmBI. The ligation site between synthons translates to a GlyGly
sequence in the final protein. BsaI and BsmBI restricted synthons
retain a protection group on one end with orthogonal 59-AAAA
overhangs. Entry synthons were processed during three recursive
assembly cycles. Relatively short reaction times (10–15 min) at
ligase concentrations of 1 unit sufficed to covalently link
complementary synthons with excellent yield (Fig. 3A,B). We
note, however, that we did not assess the efficiency of our
approach with overhang sequences other than the cohesive
GGGG/CCCC system exemplified in this report.
Using this protocol it proved feasible, in one working day, to
assemble the series of constructs comprising one up to eight
13FNIII synthons (denoted (
13FNIII)1 through (
13FNIII)8; Fig. 3C).
The cumulative yield loss resulting from repeated restriction-
ligation cycles and associated gel purifications prohibited the
assembly of even larger constructs. This should be possible,
however, by increasing the amount of starting material. Alterna-
tively, selected assemblies could be ligated back into the empty
entry vector and amplified in bacterial cultures for further
processing (see Fig. 1). Compared to conventional methods based
on sequential subcloning (e.g. BamHI/BgIII system), our ap-
proach saved at least 9 days to yield the largest (
13FNIII)8 construct
(Fig. 3C). Finally, the composite synthons were ligated into the
pShuttle vector, as well as the donor/acceptor vectors pDA-N and
pDA-C from which they may be recombined with other synthons
to yield heterocomposite constructs (see below).
In a similar fashion we constructed multimeric constructs
containing tandem repeats encoding residues Val1478 to
Gly1674 of the human von Willebrand factor A2 domain
(VWFA2). In this case we used the donor and acceptor vector
system to clone the assembled (A2)2, (A2)4 and (A2)6 repeats into
both of the pDA-N and pDA-C vectors and then combined the
appropriate donor synthons and acceptor vectors (see Fig. 2B)t o
construct the final (A2)6, (A2)8 and (A2)10 assemblies for
recombinant protein expression. The VWFA2 domain has a
roughly spherical shape of ,30 A ˚ diameter with the amino- and
carboxyl-termini protruding from the same side of the domain
[18,19]. To facilitate independent folding and to prevent steric
Figure 2. Vectors for synthon recombination and transfer to expression plasmids. (A) Deprotected synthons can be ligated into a BsaI-
digested shuttle vector (pShuttle) that contains 59-BamHI and 39-NotI restriction sites compatible with our in-house collection of expression vectors.
(B) For applications that require modular recombination or insertion of individual elements, synthons can be ligated into the modular assembly
vectors pDA-N or pDA-C. pDA-N vectors that carry synthons encoding amino-terminal elements of protein constructs (1) can be combined with
synthons encoding carboxyl-terminal elements from pDA-C vectors (2) to yield a composite product (3a), optionally leaving an additional entry point
via BsaI restriction sites to insert additional synthons (3b). Final assemblies (3a and 4) contain 59-BamHI and 39-NotI restriction sites for transfer into
expression vectors.
doi:10.1371/journal.pone.0037617.g002
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molecule experiments, we engineered (GlySer)3 repeats on either
side of the domain. The resulting 12-residue linker, together with
amino- and carboxyl-terminal residues that appear unstructured
form the crystal structure [18], leads to an average end-to-end
distance of at least 16 A ˚ between the termini of adjacent domains
in the concatameric construct as estimated by the worm-like
chain model [20].
To verify our assembly format, constructs (
13FNIII)2,4,6,8 and
(A2)6,8,10 were expressed in HEK293-EBNA1 (HEK-E) cells and
purified by immobilized metal affinity chromatography followed
by size exclusion chromatography (Fig. 4A-D). We performed
thermal denaturation assays to assess the folding state of the
purified proteins and to investigate the effect of repeat number on
thermal stability. All constructs display a two-state unfolding
transition from a stable fluorescence baseline (Fig. 4E,F). We
observed a gradual decrease in melting temperature (Tm) with
increasing number of tandem repeats for the concatameric
(
13FNIII)n constructs (Table 2). Consistently, the unfolding
temperature of 62.360.2uC for the dimeric
13FNIII construct is
lower than the value of 72uC reported for the monomer [21]. In
contrast, the series of concatameric VWFA2 constructs showed
little variation in thermal stability. We have previously reported on
the modulation of thermodynamic and mechanical stability of
VWFA2 by binding of Ca
2+ to a highly conserved calcium-binding
site [18]. In accordance, we find a marked Tm shift for buffer
conditions containing either Ca
2+ or EDTA for the tandem
domain constructs, indicating that the VWFA2 domains fold into
their native structure also in this repetitive context.
Recombinant expression of repetitive DNA sequences carries
the risk of genetic instability, potentially resulting in synthesis of
truncated or rearranged protein chains. Contrary to our concerns,
we found very little contaminants in the supernatant of expression
cultures with a molecular weight different from that expected from
Figure 3. Efficient synthon assembly with split-and-pool reactions. (A) Equimolar amounts of BsaI or BsmBI deprotected
13FNIII synthons
were incubated with 1 unit of T4 ligase and product formation was assessed at different time points (left panel) or after 15 min in buffer conditions
with and without 15% (w/v) PEG6000 (right panel). (B) No significant differences in assembly efficiency are observed after 159 incubation at ligase
concentrations ranging from 1 to 10 units. (C) Performance of split-and-pool assembly in comparison to sequential approaches. Within one day the
comprehensive series of (
13FNIII)1 to (
13FNIII)8 repeats can be assembled with the split-and-pool approach (spectrum circles) and ligated into the
pShuttle vector. After a single cloning step expression plasmid is obtained on day 3. In comparison, sequential assembly with e.g. the BamHI/BglII
system requires 12 days to obtain the (
13FNIII)8 construct.
doi:10.1371/journal.pone.0037617.g003
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Although we did not perform transcriptional analysis to assess
whether these contaminating bands are a consequence of genetic
recombination or proteolysis, our data indicates genetic instability
is not a major problem in HEK-E cells for our constructs.




Repetitive constructs are frequently used in single-molecule
experiments for reasons of accelerated data sampling and
confidence in distinguishing specific tethers from non-specific
background. However, such constructs can hamper the identifi-
cation of intermediates owing to simultaneous unfolding of
structural elements in other domains of the repetitive context. In
such cases, the unambiguous assignment of unfolding traces is
facilitated if individual domains of interest are sandwiched
between a repetitive series of protein domains whose elastic
Figure 4. Expression and characterization of
13FNIII and VWFA2 tandem repeat proteins. Superposed elution profiles from size exclusion
chromatography of (
13FNIII)2–8 proteins (A) and (VWFA2)6–10 (B). (C,D) Coomassie stained SDS-PAGE of the purified proteins. (E,F) Unfolding curves
from Thermofluor analysis suggest that the concatameric constructs are properly folded. Note the consistent shift of the (VWFA2)n unfolding curves
in the presence and absence of Ca
2+.
doi:10.1371/journal.pone.0037617.g004

















(VWFA2)6 + EDTA 44.760.1
(VWFA2)8 + EDTA 43.360.3
(VWFA2)10 + EDTA 43.160.1
doi:10.1371/journal.pone.0037617.t002
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domains of titin [13,14], Dyctostelium discoideum filamin (ddFLN)
[22] or fibronectin FNIII domains [17]. Our donor and acceptor
vectors support the rapid assembly of such constructs and we
illustrate this process by sandwiching single VWFA2 domains
between amino- and carboxyl-terminal
13(FNIII)2 repeats
(Fig. 5A). For this purpose, a
13(FNIII)2-X-
13(FNIII)2 vector
construct was created that contains inversely oriented BsaI sites
between the
13FNIII repeats to form the entry point for synthon
insertion (see Fig. 2B).
13(FNIII)2 synthons were subcloned into
both pDA-N and pDA-C vectors and subsequently recombined by
ligating the BsmBI/BamHI fragment from the resulting pDA-
N-
13(FNIII)2 vector (acting as the donor) into the BsmBI/BamHI-
linearized pDA-C-
13(FNIII)2 vector (acting as the acceptor). A
synthon encoding residues Val1478 to Gly1674 of the VWFA2
domain and flanking (GlySer)3 linkers was subsequently inserted
between the
13(FNIII)2 repeats using the BsaI restriction sites. The
successful assembly was verified by PCR (Fig. 5A).
Discussion
We have demonstrated that the application of IIS restriction
endonucleases can be readily combined with a simple protecting
group concept to create a versatile framework for the rapid
assembly of modular DNA building blocks into functional gene
constructs. Several features distinguish our approach from
previously reported strategies: Contrary to conventional restriction
enzyme or recombination-based methods that require subcloning
steps between consecutive assembly cycles, the application of
Figure 5. Assembly of chimeric constructs and one-pot concatamer formation. (A) Assembly of (FNIII)2-VWFA2-(FNIII)2 sandwich constructs
from a modular assembly vector (top). PCR amplification with specific primers (indicated above the lanes; Table S1) show that the A2 synthon is
sandwiched between two
13FNIII repeats. (B) One-pot concatamer formation with orthogonal chain stoppers. Fully deprotected synthons are mixed
in different molar ratios with orthogonal chain stoppers (equivalent synthons with protecting groups on one end). Increasing the concentration of
chain stoppers shifts the size distribution towards shorter concatamers. Molar ratios of unprotected synthons:chain stoppers are indicated at the top
of the lanes. Bands marked with asterisks presumably correspond to circularized dimers.
doi:10.1371/journal.pone.0037617.g005
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idempotent composite synthons permits assembly of any arbitrary
sequence of modular DNA units into a functional gene product
in vitro. As we illustrate with the construction of
13FNIII and
VWFA2 tandem repeats, this approach considerably accelerates
the assembly procedure. One detriment that comes with our
strategy is that it requires repeated cycles of gel purification,
making it labor-intensive and, as of yet, unsuitable for automation.
Considering the remarkable efficiency of the ligation reactions that
we observed in the assembly steps process, one could consider
omitting the purification steps and submit samples to direct split-
and-pool reaction cycles. This will be applicable only if the project
concerns the construction of a series of homologous repeats, since
obviously even spurious reactive contaminants are unacceptable if
a defined set of heterogeneous synthons is to be assembled into a
particular sequence.
Several multi-fragment strategies [5,7,16,23] that have been
recently developed to address a similar scenario depend on a
distinct pair of cohesive overhang sequences for each sub-
fragment. Due to restricted redundancy of the genetic code, this
becomes a limitation if the amino acid sequences of the linkers
between domains are to be identical. The concept of orthogonal
protecting groups straightforwardly bypasses these constraints and
linker sequences can be readily standardized by appropriate
primer design. Common to all cloning strategies that rely on
restriction enzymes, however, our approach is hampered by the
probability of the recognition sequences to occur within the target
gene fragments. Although these sites may be removed by silent
mutagenesis or excluded a priori by employing custom-designed
synthetic gene units, this may represent a limitation regarding
applications that involve larger DNA modules. Alternative to the
presented sequential assembly strategy, mixtures of products with
a varying repeat number can be obtained by mixing fully
deprotected synthons with singly deprotected synthons acting as
orthogonal chain stopper units. Depending on the stochiometric
ratios used for these reactions, libraries of composite modules can
be constructed in a one-pot reaction (Fig. 5B).
We introduce further versatility by establishing a three-point
entry vector system based on donor and acceptor vectors. These
vectors form a cassette framework for the rapid modification of
open reading frames to revise assemblies that have failed in
recombinant expression trials, the insertion of mutated or
truncated synthons or to sandwich target domains between
internal standards in force spectroscopy applications.
Perspective
The directional in vitro assembly strategy based on orthogonal
protecting groups is robust, technically simple and can be readily
tailored to suit individual assembly scenarios. We anticipate that
our method will significantly facilitate and accelerate protein
engineering for single-molecule force spectroscopy experiments,
and may find broader applicability in other settings involving the
reconstitution and modification of complex modular sequences.
Supporting Information
This text contains supplementary figures.
Methods
General
Sequences of oligonucleotides are provided in Table S1. All
entry synthons and vectors were verified by DNA sequencing.
Preparation of DNA Synthons
A DNA fragment encoding residues 1813-1901 of human
13FNIII (UniProt accession P02751) flanked by 59-BsmBI-BsaI and
39-BsaI-BsmBI restriction sites was optimized for mammalian
codon usage, RNA structure, and GC content and synthesized
(DNA 2.0, Menlo Park, CA). Overhang sequences were chosen as
AAAA for the protection group overhangs and GGGG for the
cohesive overhangs in the 59-BsmBI-BsaI sequence vs. AAAA and
CCCC for protection group and cohesive overhangs in the 39-
BsaI-BsmBI sequence (compare Fig. 1A). To preserve the reading
frame the 39 CCCC bases are preceded by two additional C
nucleotides. A DNA fragment encoding residues 1478-1674 of the
human VWFA2 domain (UniProt accession P04275; p.V1565A
polymorphism) and containing the same overhang sequences was
constructed as described [18] using oligos VWFA2.fw and
VWFA2.rev. A silent mutation was introduced by QuikChange
mutagenesis to remove the internal BsmBI site in the A2 fragment.
Both constructs were cloned into pCR8-TOPO (Invitrogen) for
DNA amplification.
Construction of Shuttle and Donor/acceptor Vectors
A DNA stuffer fragment encoding part of the VWF cDNA was
amplified by PCR with oligos containing a 59-BamHI-BsaI-BsmBI
sequence for pDA-N (oligos pDA-N.fw and pDA-N.rev) or a 59-
NotI-BsaI-BsmBI sequence for pDA-C (oligos pDA-C.fw and
pDA-C.rev), respectively. The PCR products were then cloned
into pCR8-TOPO and a fragment of the stuffer sequence
containing internal BsaI sites was excised by NsiI digestion to
create the donor/acceptor vectors pDA-N and pDA-C, respec-
tively. The plasmid backbone of pCR8-TOPO does not contain
internal BsaI, BsmBI or BsmAI sites. Similarly, the pShuttle vector
was obtained from PCR amplification of the stuffer fragment using
oligos pShuttle.fw and pShuttle.rev.
Assembly of
13FNIII and VWFA2 Repeats
Plasmid DNA of pCR8-
13FNIII and pCR8-VWFA2 was
prepared from 50 mL o/n cultures using a Midiprep kit (Sigma
Aldrich) and concentrated by ethanol precipitation to ob-
tain ,0.7 mg DNA at 1.5–2.5 mg/ml. 50–100 mg DNA were
mixed with 10x NEB reaction buffer 3 and either 5 ml BsaI or
BsmBI (New England Biolabs) in a total volume of 50–100 ml and
incubated at 50uC for 1 h on a thermal cycler (Bio-Rad S1000).
After a 30 min gel electrophoresis run on 2% (w/v) agarose gels,
synthon fragments were excised and gel purified using a DNA gel
purification kit (Promega). Usually around 10.5 mgo f(
13FNIII)-
mono synthon were recovered (, 85 % yield). Equal molar amounts
(typically 250–500 ng at , 100 – 250 ng/ml ) of orthogonally
protected synthons were mixed, 0.5–1 unit T4 ligase (Fermentas)
and T4 ligase buffer (Fermentas) were added and the ligation
mixture was incubated for 10–20 min at 16uC. Adding additional
ligase had little effect on ligation efficiency. A 30 min gel
electrophoresis run on 0.8–1.5 % (w/v) agarose gels provided
sufficient separation of product from unreacted synthons. Product
synthons were gel purified as described above and split into two
equal volumes, which were treated with either BsaI or BsmBI to
yield orthogonally protected dimers. This assembly process was
repeated until the target constructs were obtained. For further
processing, the target synthons were digested for 30 min with BsaI
and BsmBI to deprotect both ends and purified over a DNA
purification spin column (Promega). 1 mg pShuttle, pDA-N and
pDA-C vectors were digested with BsaI for 1 h at 50uC after
which the vectors were dephosphorylated by the addition of 0.5
units shrimp alkaline phosphatase (SAP, Fermentas) for 1 h at
37uC. We found that self-ligation could be significantly reduced by
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(FNIII)n synthons were ligated directly into the BsaI-linearized
pShuttle vector whereas (A2)n constructs were ligated into pDA-N
and pDA-C donor and acceptor vectors using low vector
concentrations of 0.3–0.6 ng/ml and vector:insert ratios below
4:1, which we found to reduce synthon self-assembly.
Assembly of (FNIII)2-(VWFA2)-(FNIII)2 Constructs
(FNIII)2 synthons were assembled as described above and
ligated into BsaI-linearized pDA-N and pDA-C vectors. Next, the
(FNIII)2 synthon was digested from the pDA-N-(FNIII)2 vector
(3 mg) using BsmBI and BamHI and ligated into the BsmBI/
BamHI-linearized pDA-C-(FNIII)2 acceptor vector. The resulting
vector pDA-(FNIII)2-X-(FNIII)2 was linearized with BsaI to create
an entry point for the A2 synthon. The BsmBI/BsaI deprotected
A2 synthon was subsequently ligated into the linearized vector to
create the chimeric pDA-(FNIII)2-A2-(FNIII)2 construct.
Protein Expression and Purification
Tandem repeat constructs of
13FNIII and VWF-A2 were ligated
into the BamHI and NotI sites of a modified pTT3 vector carrying
a cystatin S signal peptide, an amino-terminal hexahistidine tag
and a carboxyl-terminal biotin acceptor peptide sequence
(GLNDIFEAQKIEWHE). Human embryonic kidney cells stably
expressing EBNA1 were transiently transfected as described [24].
Proteins were purified by Ni-sepharose affinity chromatography
(GE Healthcare), followed by size exclusion chromatography in
20 mM HEPES (pH 7.5), 150 mM NaCl on Superdex 200 10/
300 column (GE Healthcare). Proteins were concentrated to
1 mg/mL and stored at 280uC.
Thermal Denaturation Assays
Thermal denaturation assays were performed essentially as
described [18]. Briefly, 6.25 ml of 10x Sypro Orange (Sigma-
Aldrich) was mixed with 6.25 ml of a 0.4 mg/mL protein solution
in 20 mM HEPES (pH 7.5), 150 mM NaCl and immediately
mixed with 12.5 ml of assay buffer containing 50 mM HEPES
(pH 7.5), 150 mM NaCl for
13FNIII concatamers or assay buffer
containing additionally 1 mM CaCl2 or 5 mM EDTA for VWFA2
concatamers. The apparent Tm of individual unfolding curves
(n=3) was determined from a sigmoidal fit to the normalized
fluorescence data [25].
Supporting Information
Figure S1 Western blot of (VWFA2)n in expression
medium demonstrating minor contamination by con-
catamers with a molecular weight different from the
target construct (indicated by arrows). These contaminants
may either result from genetic recombination or proteolysis. Horse
radish peroxidase-coupled a-VWF (Dako) was used to stain the
blot.
(TIF)
Table S1 Oligonucleotide sequences.
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